<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Genetics</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CF2CDFC8-EEDB-4972-A401-69F354779273"><gtr:id>CF2CDFC8-EEDB-4972-A401-69F354779273</gtr:id><gtr:firstName>Flaviano</gtr:firstName><gtr:surname>Giorgini</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700090"><gtr:id>BA973670-06A9-4AC5-A8BE-1C48B31627EC</gtr:id><gtr:title>Characterisation of candidate therapeutic targets for Huntington disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700090</gtr:grantReference><gtr:abstractText>Huntington disease is a fatal hereditary disorder that is characterised by the formation of lesions in the brain. It is a late onset disease in which patients exhibit involuntary movements, rigidity, and dementia. Though a great amount of work has been focused on this disease in recent years, no effective therapy is yet available for Huntington disease. 
Genetic analysis in bakers yeast has been used extensively as a fast and easy approach to study genetics and cellular processes. We have previously used a yeast model of Huntington disease to identify a candidate therapeutic target for this disease, which has recently been validated in preclinical trials in a mouse model of Huntington disease. 
Here, we propose to validate additional candidate therapeutic targets identified in yeast in mammalian cells. In addition, we will use yeast to characterise the genetic interactions among the identified modifiers. Ultimately, we feel this work will elucidate the molecular mechanisms of pathogenesis in Huntington disease as well as inform novel therapeutic approaches for this disorder.</gtr:abstractText><gtr:technicalSummary>Huntington disease is a fatal neurodegenerative disorder inherited in an autosomal dominant manner. Though a great amount of work has been focused on this disease in recent years, no effective therapy is yet available. We have identified many candidate therapeutic targets for this disorder via a genomic screen in yeast. Recently, we have validated one of these targets in mammalian cells and in a mouse model of Huntington disease, indicating that this is a valid approach for identifying novel drug targets for this disorder. The major goals of the proposed studies are to use molecular genetic approaches to validate the additional candidate therapeutic targets and to thereby dissect the pathogenic pathways causing neurodegeneration in Huntington disease. Here we propose to identify additional genes that modulate toxicity in a yeast model of Huntington disease by testing candidate genes identified in gene expression profiling experiments. In addition, we will dissect the genetic interactions among these genes and other genetic modifiers of toxicity identified in a yeast model of Huntington disease. Finally, we will validate the modifiers of toxicity in mammalian cell models of Huntington disease.</gtr:technicalSummary><gtr:fund><gtr:end>2011-02-28</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>337752</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Prof Charalambos Kyriacou</gtr:description><gtr:id>4F2C98CA-D8C0-47D6-B9A0-D51D90CCEB59</gtr:id><gtr:impact>Several of the publications listed in the portfolio have arisen from our collaboration (as indicated by the presence of Prof Kyriacou on the author list).</gtr:impact><gtr:partnerContribution>Prof Kyriacou has advised on the use of fruit fly models in our work.</gtr:partnerContribution><gtr:piContribution>I have brought expertise on Huntington's and Parkison's disease models to this project, as well as our knowledge on the study of genetic modifiers of disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kent</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Prof Mick Tuite</gtr:description><gtr:id>F031D83F-9987-48D0-84C4-8EB57B0C4E5E</gtr:id><gtr:impact>Not yet applicable.</gtr:impact><gtr:partnerContribution>Prof Tuite is performing parallel analyses in yeast.</gtr:partnerContribution><gtr:piContribution>We are studying the role of aggregation prone proteins (RNQ1) in influencing mutant huntingtin toxicity in fruit flies and mammalian cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interview BBC Radio Leicester</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>2171793B-6B90-4DC5-ADFA-79BB918B2234</gtr:id><gtr:impact>Discussion with host/interviewer.

Increased information requests from the public about our research.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University Taster Days</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>754C9762-D1F6-4DDA-9868-365FFF938637</gtr:id><gtr:impact>~100 A-level students contemplating Leicester for undergraduate studies, along with parents/relatives. These talks covered my research, and the students asked several relevant questions, and were interested in how this could tie into their 3rd projects. This has been done 7 times, 6 times in Leicester and once in London.

Impacts will be determined based upon potentially increased applications to the university for study.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2012,2013,2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at YES Meeting 2008, Porto (Portugal)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2A868ED2-59C4-41B1-BB98-272025ADCBC7</gtr:id><gtr:impact>The audience was primarily medical students interested in medically-related research. The students came from throughout Europe. The conference was 4 days long, and I presented a seminar, as well as judged posters and student talks.

Increased correspondence from potential PhD student candidates that attended the meeting. This will likely result in recruitment of a new PhD student for my group that is funded by external sources.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Inaugural Lecture, University of Leicester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>ECD09899-3672-4825-80F4-3EEDDB0290B8</gtr:id><gtr:impact>This was my inaugural lecture for promotion to professorship, which was a public lecture/event. A mix of individuals from the university and the local community attended. Estimate ~200 people attended.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Neuroscience Day, University of Leicester (UK)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>00939122-B6C7-4B72-A0EB-4794652D50FE</gtr:id><gtr:impact>The Neuroscience Day event at the University of Leicester is an annual event which brings together local researchers from our university as well as nearby universities that are interested in neuroscience research. The day includes speakers and poster sessions. Members of the public are also encouraged to attend.

This activity allowed us to disseminate our MRC-funded research to the public and also to potential collaborators in the region. This will likely lead to additional funding opportunities for the work and advancement of the science.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker to Medical Students, Leicester (UK)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EC36C32E-98A0-45A3-8304-34D3189AF6BD</gtr:id><gtr:impact>I am a speaker in a series of seminars giving to University of Leicester medical students describing research at the university. Work for our project was described in this seminar.

This presentation has led to interest in our research from medical students searching for research projects.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at European Huntington's Disease Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>143C4AF1-B6D6-4D05-A8BE-F00382F5FB65</gtr:id><gtr:impact>Conference attended by over 500 individuals; researchers, clinicians, patient groups, and the public. A poster on our MRC-funded research was presented.

Our poster was attended by members of the Mill Lodge NHS Clinic, and sparked my visit to their facilities and future outreach activities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited seminar, Center for Neuroscience and Cell Biology of the University of Coimbra, Coimbra, Portugal.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F8DD0EC9-32E9-4BB5-B17C-5A04699227E2</gtr:id><gtr:impact>I presented two seminars on Huntington's disease and my research to postgraduate students as part of a course on neurological diseases.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GENIE Open Day Events, University of Leicester, UK</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5FF2425B-A9AD-4C8E-8F33-963573525B29</gtr:id><gtr:impact>Open day events organized by GENIE a CETL based at the University of Leicester. ~200 school children per event learning about DNA and genetics, and the use in medicine, etc.

Generated interested in genetics amongst the school children - with greater interest in GCSE and A-level science/biology.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview BBC East Midlands Today</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D9A634C3-8656-466D-AD83-3D23683672BD</gtr:id><gtr:impact>Discussion with host/interviewer.

More interest from the public about our research.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain Awareness Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>135B211D-4355-41DC-B18A-8E00CDF2A1BB</gtr:id><gtr:impact>My lecture was part of a wider Brain Awareness Day event which the University of Leicester organized. It was broadly advertised and well attended. My lecture served to spark many questions from the audience how basic research using disease models can lead to advances in medicine and treatment.

The talk led to increased interest in my research, and hopefully emphasized to the audience the translational benefits of our studies.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Mill Lodge NHS Psychiatric Clinic</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>62FF9A45-CEB4-460B-9391-3A6C959CC708</gtr:id><gtr:impact>10 Huntington's disease patient carers (consultants, nurses) attended a talk about our MRC-funded research, followed by questions and discussion.

Planning of future outreach activities from my research group with patients and families organized in collaboration with Mill Lodge.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GENIE Summer School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AE5AB580-6B5D-4DA6-9DCD-BEFA8904623F</gtr:id><gtr:impact>Talk sparked discussion/questions.

Increased interest in science/genetics amongst students.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public lecture - Huntington's Carers Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4D722B7B-CB3E-4573-B19B-6C0C43FF7590</gtr:id><gtr:impact>~20 members of the public attended a public lecture in Leicester focosed on the local Huntington's carers.

We received positive response from the attendees due to a heightened awareness of what academic disease research entails.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at National Centre for the 3Rs in Leicester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9CA8DD98-9443-4E33-A173-CB439DBE2DCB</gtr:id><gtr:impact>100 members of the public and the university community attended a symposium sponsered by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs); I was one of the talks. I discussed using simple organisms to study Huntington's disease in the context of my MRC funded work.

Based upon my seminar I was selected by the University of Leicester as a candidate supervisor for the NC3Rs PhD studentships. This application has been submitted and is currently under review.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GENIE Public Lecture, University of Leicester, &quot;Targeting genes for therapy in neurodegenerative disease&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>44E01AAE-1F0C-4666-BD53-E071B714E0EF</gtr:id><gtr:impact>~100 members of the regional public attend this lecture organized by the University of Leicester. Questions and discussion followed.

Enquiries received from 6th form students about lecture content.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>50th Anniversary for Department of Genetics, University of Leicester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1C3AFA42-927F-4710-A54E-6EBD8FA8D8D2</gtr:id><gtr:impact>Seminar was presented, which resulted in discussion.

Discussion of interest from public and colleagues.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Walk Museum - Inside DNA lecture series</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>DEF48DF2-1F73-471B-A893-486A0FF0FA05</gtr:id><gtr:impact>~30 members of the public attend this lay talk about my research at the New Walk Museum in Leicester. This seminar was part of a series entitled &amp;quot;Inside DNA Lecture Series&amp;quot;.

Increased awareness by the public of the nature of disease research.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster HDF HD2008, Boston (USA)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EA9B3F84-1582-4B0B-BC9A-BAB4CA892E40</gtr:id><gtr:impact>Early results from this project were presented at the Hereditary Disease Foundation's Huntington's Disease 2008 meeting in Boston (USA), a leading international meeting on Huntington's disease research. Approximately 400 individuals attended, including academics, clinicians, and patients. The meeting lasted 4 days, and the postdoctoral researcher presenting the poster received positive feedback from several participants that came to her poster.

Our presentation let to discussion of results with interested colleagues that informed our research methods, as well as established potential for future collaboration.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Archbishop Desmond Tutu, University of Leicester, &quot;Targeting genes for therapy in neurodegenerative disease&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F75D256F-4FC5-4FE4-9AD8-041A534B8F0D</gtr:id><gtr:impact>A private audience with Archbishop Desmond Tutu with a few other University of Leicester academics. Questions and discussion followed.

Photos from this event were featured on the university website and in the local press.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>49720</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>European Huntington's Disease Network (Euro-HD)</gtr:department><gtr:description>EHDN Seed Fund Grant</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:fundingRef>466</gtr:fundingRef><gtr:id>DEAB150F-B597-47BC-815E-57219A702002</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Neurosciences and Mental Health Board (NMHB) Strategy Meeting</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>594D0C7F-57E1-409C-BD6F-7F9B951B8A9D</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Scientific and Bioethics Advisory Committee for EHDN (co-chair from 2014, Chair from 2016)</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>BA8A9544-56B7-4ED5-A18D-462C5BE1D55E</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have generated three transgenic fly models which express mammalian cDNAs that suppress mutant htt toxicity based upon our studies. The lines express one of the following: Gpx1, Pdhb, Snx1. These lines are currently being crossed to Huntington's disease model flies to test whether they rescue disease-relevant metrics in this model.</gtr:description><gtr:id>783A0375-EF60-40E1-B086-69F37AFDB6F0</gtr:id><gtr:impact>The most important impact would be the validation of these candidate suppressors in vivo in an animal model. If we do indeed validate, then this would lead to publications, as well as future funding opportunities to test these candidates in mouse models.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Transgenic fly models</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have generated several mutant huntingtin expressing neuronal cell lines that contain stably-expressing shRNA constructs for RNAi targeting of candidate loss of function modifiers of mutant huntingtin toxicity.</gtr:description><gtr:id>352EAFD6-B7D1-4BF1-94E9-9542C3D69B50</gtr:id><gtr:impact>Generation of these materials has allowed our group to validate loss of function suppressors in mammalian cells that we identified in yeast. These cell lines will be made freely available to other researchers upon request.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Stable cell lines expressing shRNA constructs</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/923A7B84-5031-4D15-BC3E-903A66404AD7"><gtr:id>923A7B84-5031-4D15-BC3E-903A66404AD7</gtr:id><gtr:title>Modeling Huntington disease in yeast: perspectives and future directions.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2fd1caf8f71cf1886054e41990cc9dd"><gtr:id>f2fd1caf8f71cf1886054e41990cc9dd</gtr:id><gtr:otherNames>Mason RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9DCA3917-B957-4F75-9C11-1B33B8F31490"><gtr:id>9DCA3917-B957-4F75-9C11-1B33B8F31490</gtr:id><gtr:title>Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/78b50134f3d0c93a1e8b51d9079ed612"><gtr:id>78b50134f3d0c93a1e8b51d9079ed612</gtr:id><gtr:otherNames>Tauber E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0920D8EA-4280-4FA8-94D3-9B5AA2AC4145"><gtr:id>0920D8EA-4280-4FA8-94D3-9B5AA2AC4145</gtr:id><gtr:title>Glutathione peroxidase activity is neuroprotective in models of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2fd1caf8f71cf1886054e41990cc9dd"><gtr:id>f2fd1caf8f71cf1886054e41990cc9dd</gtr:id><gtr:otherNames>Mason RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14F7492C-F7FD-4E9A-9EE9-54FF5CA5E435"><gtr:id>14F7492C-F7FD-4E9A-9EE9-54FF5CA5E435</gtr:id><gtr:title>Aggregation-prone proteins modulate huntingtin inclusion body formation in yeast.</gtr:title><gtr:parentPublicationTitle>PLoS currents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2871767c158f45ea69a8e2d29ff9b9e4"><gtr:id>2871767c158f45ea69a8e2d29ff9b9e4</gtr:id><gtr:otherNames>Kantcheva RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BBC329C-99BC-4028-89B6-18FF3FE4C1ED"><gtr:id>6BBC329C-99BC-4028-89B6-18FF3FE4C1ED</gtr:id><gtr:title>Is modulating translation a therapeutic option for Huntington's disease?</gtr:title><gtr:parentPublicationTitle>Neurodegenerative disease management</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/752520e6f928033e03710d1f362ab1b6"><gtr:id>752520e6f928033e03710d1f362ab1b6</gtr:id><gtr:otherNames>Giorgini F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1758-2024</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/832360B7-B72A-44D3-B6D7-51E6A1E3CD9B"><gtr:id>832360B7-B72A-44D3-B6D7-51E6A1E3CD9B</gtr:id><gtr:title>Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d61dac223e86505678cc21f7cceac5e"><gtr:id>8d61dac223e86505678cc21f7cceac5e</gtr:id><gtr:otherNames>Vittori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2A3620F9-1C52-44DB-A44D-F29F6A042F68"><gtr:id>2A3620F9-1C52-44DB-A44D-F29F6A042F68</gtr:id><gtr:title>Targeting kynurenine 3-monooxygenase (KMO): implications for therapy in Huntington's disease.</gtr:title><gtr:parentPublicationTitle>CNS &amp; neurological disorders drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ff86cafbfacbcc1e4d4f81cffa528486"><gtr:id>ff86cafbfacbcc1e4d4f81cffa528486</gtr:id><gtr:otherNames>Thevandavakkam MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1871-5273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E122D62-3E46-443B-AB14-56F8170B64E7"><gtr:id>5E122D62-3E46-443B-AB14-56F8170B64E7</gtr:id><gtr:title>?-Defensin genomic copy number does not influence the age of onset in Huntington's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Huntington's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d61dac223e86505678cc21f7cceac5e"><gtr:id>8d61dac223e86505678cc21f7cceac5e</gtr:id><gtr:otherNames>Vittori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1879-6397</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6284C031-EBC5-4699-B523-554330C732E7"><gtr:id>6284C031-EBC5-4699-B523-554330C732E7</gtr:id><gtr:title>Exploiting yeast genetics to inform therapeutic strategies for Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/752520e6f928033e03710d1f362ab1b6"><gtr:id>752520e6f928033e03710d1f362ab1b6</gtr:id><gtr:otherNames>Giorgini F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F52F25D-A255-461E-B33F-59F63CF76F76"><gtr:id>7F52F25D-A255-461E-B33F-59F63CF76F76</gtr:id><gtr:title>Connectivity mapping uncovers small molecules that modulate neurodegeneration in Huntington's disease models.</gtr:title><gtr:parentPublicationTitle>Journal of molecular medicine (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f86a9c2b9c1d0151ccaab6ff4078a4b3"><gtr:id>f86a9c2b9c1d0151ccaab6ff4078a4b3</gtr:id><gtr:otherNames>Smalley JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0946-2716</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B34968D0-4704-4EE8-AF45-EC12C82117C1"><gtr:id>B34968D0-4704-4EE8-AF45-EC12C82117C1</gtr:id><gtr:title>Yeast as a model for studying human neurodegenerative disorders.</gtr:title><gtr:parentPublicationTitle>Biotechnology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ef66a4a01c5ecdfeac355040cb4f341"><gtr:id>1ef66a4a01c5ecdfeac355040cb4f341</gtr:id><gtr:otherNames>Miller-Fleming L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1860-6768</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700090</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>